Hallucinations, sleep fragmentation, and altered dream phenomena in Parkinson's disease

In a series of consecutively randomized outpatients who had Parkinson's disease (PD), we examined the association of three behaviors: sleep fragmentation, altered dream phenomena, and hallucinations/illusions. Using a log‐linear model methodology, we tested the independence of each behavior. Si...

Full description

Saved in:
Bibliographic Details
Published inMovement disorders Vol. 14; no. 1; pp. 117 - 121
Main Authors Pappert, Eric J., Goetz, Christopher G., Niederman, Francie G., Raman, Rema, Leurgans, Sue
Format Journal Article
LanguageEnglish
Published New York John Wiley & Sons, Inc 01.01.1999
Wiley
Subjects
Online AccessGet full text
ISSN0885-3185
1531-8257
DOI10.1002/1531-8257(199901)14:1<117::AID-MDS1019>3.0.CO;2-0

Cover

Abstract In a series of consecutively randomized outpatients who had Parkinson's disease (PD), we examined the association of three behaviors: sleep fragmentation, altered dream phenomena, and hallucinations/illusions. Using a log‐linear model methodology, we tested the independence of each behavior. Sixty‐two percent of the subjects had sleep fragmentation, 48% had altered dream phenomena, and 26% had hallucinations/illusions. Eighty‐two percent of the patients with hallucinations/illusions experienced some form of sleep disorder. The three phenomena were not independent. The interaction between sleep fragmentation and altered dream phenomena was strongly statistically significant. Likewise, a significant interaction existed between altered dream phenomena and hallucinations/illusions. No interaction occurred between sleep fragmentation and hallucinations/illusions. Sleep fragmentation, altered dream phenomena, and hallucinations/illusions in PD should be considered distinct but often overlapping behaviors. The close association between altered dream phenomena and hallucinations suggests that therapeutic interventions aimed at diminishing dream‐related activities may have a specific positive impact on hallucinatory behavior.
AbstractList In a series of consecutively randomized outpatients who had Parkinson's disease (PD), we examined the association of three behaviors: sleep fragmentation, altered dream phenomena, and hallucinations/illusions. Using a log-linear model methodology, we tested the independence of each behavior. Sixty-two percent of the subjects had sleep fragmentation, 48% had altered dream phenomena, and 26% had hallucinations/illusions. Eighty-two percent of the patients with hallucinations/illusions experienced some form of sleep disorder. The three phenomena were not independent. The interaction between sleep fragmentation and altered dream phenomena was strongly statistically significant. Likewise, a significant interaction existed between altered dream phenomena and hallucinations/illusions. No interaction occurred between sleep fragmentation and hallucinations/illusions. Sleep fragmentation, altered dream phenomena, and hallucinations/illusions in PD should be considered distinct but often overlapping behaviors. The close association between altered dream phenomena and hallucinations suggests that therapeutic interventions aimed at diminishing dream-related activities may have a specific positive impact on hallucinatory behavior.In a series of consecutively randomized outpatients who had Parkinson's disease (PD), we examined the association of three behaviors: sleep fragmentation, altered dream phenomena, and hallucinations/illusions. Using a log-linear model methodology, we tested the independence of each behavior. Sixty-two percent of the subjects had sleep fragmentation, 48% had altered dream phenomena, and 26% had hallucinations/illusions. Eighty-two percent of the patients with hallucinations/illusions experienced some form of sleep disorder. The three phenomena were not independent. The interaction between sleep fragmentation and altered dream phenomena was strongly statistically significant. Likewise, a significant interaction existed between altered dream phenomena and hallucinations/illusions. No interaction occurred between sleep fragmentation and hallucinations/illusions. Sleep fragmentation, altered dream phenomena, and hallucinations/illusions in PD should be considered distinct but often overlapping behaviors. The close association between altered dream phenomena and hallucinations suggests that therapeutic interventions aimed at diminishing dream-related activities may have a specific positive impact on hallucinatory behavior.
In a series of consecutively randomized outpatients who had Parkinson's disease (PD), we examined the association of three behaviors: sleep fragmentation, altered dream phenomena, and hallucinations/illusions. Using a log‐linear model methodology, we tested the independence of each behavior. Sixty‐two percent of the subjects had sleep fragmentation, 48% had altered dream phenomena, and 26% had hallucinations/illusions. Eighty‐two percent of the patients with hallucinations/illusions experienced some form of sleep disorder. The three phenomena were not independent. The interaction between sleep fragmentation and altered dream phenomena was strongly statistically significant. Likewise, a significant interaction existed between altered dream phenomena and hallucinations/illusions. No interaction occurred between sleep fragmentation and hallucinations/illusions. Sleep fragmentation, altered dream phenomena, and hallucinations/illusions in PD should be considered distinct but often overlapping behaviors. The close association between altered dream phenomena and hallucinations suggests that therapeutic interventions aimed at diminishing dream‐related activities may have a specific positive impact on hallucinatory behavior.
Author Raman, Rema
Goetz, Christopher G.
Leurgans, Sue
Niederman, Francie G.
Pappert, Eric J.
Author_xml – sequence: 1
  givenname: Eric J.
  surname: Pappert
  fullname: Pappert, Eric J.
  organization: Department of Neurological Sciences, Rush-Presbyterian-St. Luke's Medical Center, Chicago, Illinois, U.S.A
– sequence: 2
  givenname: Christopher G.
  surname: Goetz
  fullname: Goetz, Christopher G.
  organization: Department of Neurological Sciences, Rush-Presbyterian-St. Luke's Medical Center, Chicago, Illinois, U.S.A
– sequence: 3
  givenname: Francie G.
  surname: Niederman
  fullname: Niederman, Francie G.
  organization: Department of Neurological Sciences, Rush-Presbyterian-St. Luke's Medical Center, Chicago, Illinois, U.S.A
– sequence: 4
  givenname: Rema
  surname: Raman
  fullname: Raman, Rema
  organization: Department of Preventive Medicine, Rush-Presbyterian-St. Luke's Medical Center, Chicago, Illinois, U.S.A
– sequence: 5
  givenname: Sue
  surname: Leurgans
  fullname: Leurgans, Sue
  organization: Department of Preventive Medicine, Rush-Presbyterian-St. Luke's Medical Center, Chicago, Illinois, U.S.A
BackLink http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=1642246$$DView record in Pascal Francis
https://www.ncbi.nlm.nih.gov/pubmed/9918353$$D View this record in MEDLINE/PubMed
BookMark eNqVkV1v0zAUhi00NLrBT0DKBeJDWoqPP5K4IKQ1g21SoSBA4-7IjU9GIHFKnAr270lpKDdIiBtbOufxK-t9jtiBbz0xZoBPgXPxFLSEOBM6fQzGGA5PQM3gOUA6m51ensWvz94DB_NCTvk0Xz4TMb_FJvs3B2zCs0zHEjJ9hx2F8IVzAA3JITs0BjKp5YRdXdi63hSVt33V-nAShZpoHZWdvW7I97-mJ5H1LrJ1Tx25yHVkm2j9mXw7EDaqfPTWdl8rH1r_KESuCmQD3WW3S1sHujfex-zjq5cf8ot4sTy_zE8XcaF0YuLUgiQtQBiXFVmptC61SVYmTVcFZatCQZkYJ8rEOS5FKmUGynLpUieUc2TkMXu4y1137bcNhR6bKhRU19ZTuwmYGJ0Iqf8NCgClDVcDeH8EN6uGHK67qrHdDY6VDfsH496GwtZDU76owh6DRAmhkgF7t8OKrg2ho_IPwXErF7eicCsKd3IRFA4HpIiDXBzlokSO-RIFcrkv8XtV081_BP497_doyI13uVXo6cc-d7CKSSpTjVdvznGew2L-CebDP34CFzbCMA
Cites_doi 10.1007/978-3-642-72560-9_5
10.1212/WNL.50.2.515
10.1176/ajp.135.6.669
10.1001/archneur.1996.00550120077019
10.1002/cpt1971122part2397
10.1007/BF01579073
10.1007/978-1-4757-4669-3
10.1212/WNL.39.9.1219
10.1212/WNL.45.7.1305
10.1007/BF01663632
10.1212/WNL.45.4.669
ContentType Journal Article
Copyright Copyright © 1999 Movement Disorder Society
1999 INIST-CNRS
Copyright_xml – notice: Copyright © 1999 Movement Disorder Society
– notice: 1999 INIST-CNRS
DBID BSCLL
AAYXX
CITATION
IQODW
CGR
CUY
CVF
ECM
EIF
NPM
7TK
7X8
8BM
DOI 10.1002/1531-8257(199901)14:1<117::AID-MDS1019>3.0.CO;2-0
DatabaseName Istex
CrossRef
Pascal-Francis
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
Neurosciences Abstracts
MEDLINE - Academic
ComDisDome
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
Neurosciences Abstracts
ComDisDome
MEDLINE - Academic
DatabaseTitleList ComDisDome

MEDLINE
Neurosciences Abstracts
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1531-8257
EndPage 121
ExternalDocumentID 9918353
1642246
10_1002_1531_8257_199901_14_1_117__AID_MDS1019_3_0_CO_2_0
MDS1019
ark_67375_WNG_BC1LBX1B_0
Genre article
Research Support, Non-U.S. Gov't
Journal Article
GrantInformation_xml – fundername: United Parkinson Foundation
GroupedDBID ---
.3N
.GA
.GJ
.Y3
05W
0R~
10A
123
1CY
1L6
1OB
1OC
1ZS
31~
33P
3PY
3SF
3WU
4.4
4ZD
50Y
50Z
51W
51X
52M
52N
52O
52P
52R
52S
52T
52U
52V
52W
52X
53G
5VS
66C
6PF
702
7PT
8-0
8-1
8-3
8-4
8-5
8UM
930
A01
A03
AAESR
AAEVG
AAHHS
AANLZ
AAONW
AASGY
AAWTL
AAXRX
AAZKR
ABCQN
ABCUV
ABEML
ABIJN
ABJNI
ABLJU
ABPVW
ABQWH
ABXGK
ACAHQ
ACBWZ
ACCFJ
ACCZN
ACGFS
ACGOF
ACMXC
ACPOU
ACPRK
ACSCC
ACXBN
ACXQS
ADBBV
ADBTR
ADEOM
ADIZJ
ADKYN
ADMGS
ADOZA
ADXAS
ADZMN
AEEZP
AEIGN
AEIMD
AENEX
AEQDE
AEUQT
AEUYR
AFBPY
AFFPM
AFGKR
AFPWT
AFZJQ
AHBTC
AHMBA
AIACR
AITYG
AIURR
AIWBW
AJBDE
ALAGY
ALMA_UNASSIGNED_HOLDINGS
ALUQN
AMBMR
AMYDB
ASPBG
ATUGU
AVWKF
AZBYB
AZFZN
AZVAB
BAFTC
BDRZF
BFHJK
BHBCM
BMXJE
BROTX
BRXPI
BSCLL
BY8
C45
CS3
D-6
D-7
D-E
D-F
DCZOG
DPXWK
DR1
DR2
DRFUL
DRMAN
DRSTM
DU5
EBD
EBS
EJD
EMOBN
F00
F01
F04
F5P
FEDTE
FUBAC
FYBCS
G-S
G.N
GNP
GODZA
H.X
HBH
HF~
HGLYW
HHY
HHZ
HVGLF
HZ~
IX1
J0M
JPC
KBYEO
KQQ
LATKE
LAW
LC2
LC3
LEEKS
LH4
LITHE
LOXES
LP6
LP7
LUTES
LW6
LYRES
M6M
MEWTI
MK4
MRFUL
MRMAN
MRSTM
MSFUL
MSMAN
MSSTM
MXFUL
MXMAN
MXSTM
N04
N05
N9A
NF~
NNB
O66
O9-
OIG
OVD
P2P
P2W
P2X
P2Z
P4B
P4D
PALCI
PQQKQ
Q.N
Q11
QB0
QRW
R.K
RIWAO
RJQFR
ROL
RWD
RWI
RX1
RYL
SAMSI
SUPJJ
SV3
TEORI
TWZ
UB1
V2E
V9Y
W8V
W99
WBKPD
WHWMO
WIB
WIH
WIJ
WIK
WJL
WOHZO
WQJ
WRC
WUP
WVDHM
WXI
WXSBR
XG1
XV2
YCJ
ZGI
ZZTAW
~IA
~WT
AAHQN
AAIPD
AAMMB
AAMNL
AANHP
AAYCA
ACRPL
ACYXJ
ADNMO
AEFGJ
AEYWJ
AFWVQ
AGHNM
AGQPQ
AGXDD
AGYGG
AIDQK
AIDYY
ALVPJ
AAYXX
CITATION
IQODW
CGR
CUY
CVF
ECM
EIF
NPM
7TK
7X8
8BM
ID FETCH-LOGICAL-c4569-7a13e52129d8c8f455f596b977bce8bc41f69d2f6dd032733814a03d7d24dde93
IEDL.DBID DR2
ISSN 0885-3185
IngestDate Fri Jul 11 15:30:41 EDT 2025
Thu Jul 10 23:17:35 EDT 2025
Wed Feb 19 01:20:16 EST 2025
Wed Apr 02 07:22:08 EDT 2025
Tue Jul 01 02:32:36 EDT 2025
Wed Aug 20 07:26:10 EDT 2025
Wed Oct 30 10:02:08 EDT 2024
IsPeerReviewed true
IsScholarly true
Issue 1
Keywords Human
Nervous system diseases
Hallucination
Interaction
Idiopathic
Parkinson disease
Sleep disorder
Exploration
Illusion
Cerebral disorder
Fragmentation
Dream
Central nervous system disease
Adult
Degenerative disease
Nightmare
Neurological disorder
Extrapyramidal syndrome
Language English
License http://doi.wiley.com/10.1002/tdm_license_1.1
CC BY 4.0
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c4569-7a13e52129d8c8f455f596b977bce8bc41f69d2f6dd032733814a03d7d24dde93
Notes ark:/67375/WNG-BC1LBX1B-0
istex:04781029C7273B788EF76D30239A9B58F2D246DD
ArticleID:MDS1019
United Parkinson Foundation
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
PMID 9918353
PQID 21145904
PQPubID 23462
PageCount 5
ParticipantIDs proquest_miscellaneous_69562359
proquest_miscellaneous_21145904
pubmed_primary_9918353
pascalfrancis_primary_1642246
crossref_primary_10_1002_1531_8257_199901_14_1_117__AID_MDS1019_3_0_CO_2_0
wiley_primary_10_1002_1531_8257_199901_14_1_117_AID_MDS1019_3_0_CO_2_0_MDS1019
istex_primary_ark_67375_WNG_BC1LBX1B_0
ProviderPackageCode CITATION
AAYXX
PublicationCentury 1900
PublicationDate 1999-01
January 1999
1999-01-00
1999
1999-Jan
19990101
PublicationDateYYYYMMDD 1999-01-01
PublicationDate_xml – month: 01
  year: 1999
  text: 1999-01
PublicationDecade 1990
PublicationPlace New York
PublicationPlace_xml – name: New York
– name: Hoboken, NJ
– name: United States
PublicationTitle Movement disorders
PublicationTitleAlternate Mov. Disord
PublicationYear 1999
Publisher John Wiley & Sons, Inc
Wiley
Publisher_xml – name: John Wiley & Sons, Inc
– name: Wiley
References Steriade M, McCarley RW. Brainstem Control of Wakefulness and Sleep. New York, NY: Plenum Press, 1990.
Moskovitz C, Moses H, Klawans HL. Levodopa-induced psychosis: a kindling phenomenon. Am J Psychiatry 1978;135:669-675.
Friedman JH, Lannon MC. Clozapine in the treatment of psychosis in Parkinson's disease. Neurology 1989;39:1219-1221.
Goetz CG, Pappert EJ, Blasucci LM, et al. Intravenous levodopa infusions in severely hallucinating Parkinson's disease patients: high dose pharmacologic challenge does not precipitate hallucinations. Neurology 1998;50:515-517.
Nausieda PA, Glantz R, Weber S, Baum R, Klawans HL. Psychiatric complications of levodopa therapy of Parkinson's disease. Adv Neurol 1984;40:271-277.
Pappert EJ, Goetz CG, Niederman FG, Raman R, Leurgans S, Stebbins GT. Severity and temporal stability of hallucinations/illusions in Parkinson's disease: prospective, longitudinal study [Abstract]. Neurology 1997;48:A370.
Birkmayer W, Riederer P. Responsibility of extrastriatal areas for the appearance of psychotic symptoms. J Neural Transm 1975;37:175-182.
Goetz CG, Stebbins GT. Risk factors for nursing home placement in advanced Parkinson's disease. Neurology 1993;43:92-98.
Kales A, Ansel RD, Markham CH, Sharf MB, Tan T. Sleep in patients with Parkinson's disease and in normal subjects prior to and following levodopa administration. Int J Clin Pharmacol Ther 1971;12:397-406.
Sanchez-Ramos JR, Ortoll R, Paulson GW. Visual hallucinations associated with Parkinson's disease. Arch Neurol 1996;53:1265-1268.
Goetz CG, Stebbins GT. Mortality and hallucinations in nursing home patients with advanced Parkinson's disease. Neurology 1995;45:669-671.
Tanner CM, Vogel C, Goetz CG, Klawans HL. Hallucinations in Parkinson's disease: a population study [Abstract]. Neurology 1983;14:136.
Zoldan J, Friedberg G, Weizman A, Melamed E. Psychosis in advanced Parkinson's disease: treatment with ondansetron, a 5-HT3 antagonist. Neurology 1995;45:1305-1308.
Andreason NC. The Scale for the Assessment of Positive Symptoms (SAPS). Iowa City, IA: The University of Iowa, 1984.
Sharf B, Moskovitz CH, Lupton MD, Klawans HL. Dream phenomena induced by chronic levodopa therapy. J Neural Transm 1978;43:143-151.
1984; 40
1990
1978; 43
1997; 48
1993; 43
1995; 45
1971; 12
1987
1975; 37
1984
1978; 135
1998; 50
1983; 14
1996; 53
1989; 39
Moskovitz (10.1002/1531-8257(199901)14:1<117::AID-MDS1019>3.0.CO;2-0-BIB8) 1978; 135
Zoldan (10.1002/1531-8257(199901)14:1<117::AID-MDS1019>3.0.CO;2-0-BIB13) 1995; 45
Friedman (10.1002/1531-8257(199901)14:1<117::AID-MDS1019>3.0.CO;2-0-BIB14) 1989; 39
Rothenberg (10.1002/1531-8257(199901)14:1<117::AID-MDS1019>3.0.CO;2-0-BIB9) 1987
Birkmayer (10.1002/1531-8257(199901)14:1<117::AID-MDS1019>3.0.CO;2-0-BIB12) 1975; 37
Pappert (10.1002/1531-8257(199901)14:1<117::AID-MDS1019>3.0.CO;2-0-BIB15) 1997; 48
Nausieda (10.1002/1531-8257(199901)14:1<117::AID-MDS1019>3.0.CO;2-0-BIB7) 1984; 40
Sanchez-Ramos (10.1002/1531-8257(199901)14:1<117::AID-MDS1019>3.0.CO;2-0-BIB2A) 1996; 53
Goetz (10.1002/1531-8257(199901)14:1<117::AID-MDS1019>3.0.CO;2-0-BIB3) 1993; 43
Kales (10.1002/1531-8257(199901)14:1<117::AID-MDS1019>3.0.CO;2-0-BIB5) 1971; 12
Goetz (10.1002/1531-8257(199901)14:1<117::AID-MDS1019>3.0.CO;2-0-BIB4) 1995; 45
Goetz (10.1002/1531-8257(199901)14:1<117::AID-MDS1019>3.0.CO;2-0-BIB2B) 1998; 50
Andreason (10.1002/1531-8257(199901)14:1<117::AID-MDS1019>3.0.CO;2-0-BIB10) 1984
Tanner (10.1002/1531-8257(199901)14:1<117::AID-MDS1019>3.0.CO;2-0-BIB1) 1983; 14
Steriade (10.1002/1531-8257(199901)14:1<117::AID-MDS1019>3.0.CO;2-0-BIB11) 1990
Sharf (10.1002/1531-8257(199901)14:1<117::AID-MDS1019>3.0.CO;2-0-BIB6) 1978; 43
References_xml – reference: Tanner CM, Vogel C, Goetz CG, Klawans HL. Hallucinations in Parkinson's disease: a population study [Abstract]. Neurology 1983;14:136.
– reference: Moskovitz C, Moses H, Klawans HL. Levodopa-induced psychosis: a kindling phenomenon. Am J Psychiatry 1978;135:669-675.
– reference: Andreason NC. The Scale for the Assessment of Positive Symptoms (SAPS). Iowa City, IA: The University of Iowa, 1984.
– reference: Goetz CG, Stebbins GT. Risk factors for nursing home placement in advanced Parkinson's disease. Neurology 1993;43:92-98.
– reference: Kales A, Ansel RD, Markham CH, Sharf MB, Tan T. Sleep in patients with Parkinson's disease and in normal subjects prior to and following levodopa administration. Int J Clin Pharmacol Ther 1971;12:397-406.
– reference: Friedman JH, Lannon MC. Clozapine in the treatment of psychosis in Parkinson's disease. Neurology 1989;39:1219-1221.
– reference: Pappert EJ, Goetz CG, Niederman FG, Raman R, Leurgans S, Stebbins GT. Severity and temporal stability of hallucinations/illusions in Parkinson's disease: prospective, longitudinal study [Abstract]. Neurology 1997;48:A370.
– reference: Goetz CG, Stebbins GT. Mortality and hallucinations in nursing home patients with advanced Parkinson's disease. Neurology 1995;45:669-671.
– reference: Sharf B, Moskovitz CH, Lupton MD, Klawans HL. Dream phenomena induced by chronic levodopa therapy. J Neural Transm 1978;43:143-151.
– reference: Birkmayer W, Riederer P. Responsibility of extrastriatal areas for the appearance of psychotic symptoms. J Neural Transm 1975;37:175-182.
– reference: Zoldan J, Friedberg G, Weizman A, Melamed E. Psychosis in advanced Parkinson's disease: treatment with ondansetron, a 5-HT3 antagonist. Neurology 1995;45:1305-1308.
– reference: Goetz CG, Pappert EJ, Blasucci LM, et al. Intravenous levodopa infusions in severely hallucinating Parkinson's disease patients: high dose pharmacologic challenge does not precipitate hallucinations. Neurology 1998;50:515-517.
– reference: Steriade M, McCarley RW. Brainstem Control of Wakefulness and Sleep. New York, NY: Plenum Press, 1990.
– reference: Nausieda PA, Glantz R, Weber S, Baum R, Klawans HL. Psychiatric complications of levodopa therapy of Parkinson's disease. Adv Neurol 1984;40:271-277.
– reference: Sanchez-Ramos JR, Ortoll R, Paulson GW. Visual hallucinations associated with Parkinson's disease. Arch Neurol 1996;53:1265-1268.
– year: 1984
– volume: 43
  start-page: 92
  year: 1993
  end-page: 98
  article-title: Risk factors for nursing home placement in advanced Parkinson's disease
  publication-title: Neurology
– volume: 45
  start-page: 669
  year: 1995
  end-page: 671
  article-title: Mortality and hallucinations in nursing home patients with advanced Parkinson's disease
  publication-title: Neurology
– volume: 53
  start-page: 1265
  year: 1996
  end-page: 1268
  article-title: Visual hallucinations associated with Parkinson's disease
  publication-title: Arch Neurol
– volume: 50
  start-page: 515
  year: 1998
  end-page: 517
  article-title: Intravenous levodopa infusions in severely hallucinating Parkinson's disease patients: high dose pharmacologic challenge does not precipitate hallucinations
  publication-title: Neurology
– start-page: 63
  year: 1987
  end-page: 78
– volume: 12
  start-page: 397
  year: 1971
  end-page: 406
  article-title: Sleep in patients with Parkinson's disease and in normal subjects prior to and following levodopa administration
  publication-title: Int J Clin Pharmacol Ther
– volume: 39
  start-page: 1219
  year: 1989
  end-page: 1221
  article-title: Clozapine in the treatment of psychosis in Parkinson's disease
  publication-title: Neurology
– volume: 37
  start-page: 175
  year: 1975
  end-page: 182
  article-title: Responsibility of extrastriatal areas for the appearance of psychotic symptoms
  publication-title: J Neural Transm
– volume: 43
  start-page: 143
  year: 1978
  end-page: 151
  article-title: Dream phenomena induced by chronic levodopa therapy
  publication-title: J Neural Transm
– volume: 48
  start-page: A370
  year: 1997
  article-title: Severity and temporal stability of hallucinations/illusions in Parkinson's disease: prospective, longitudinal study [Abstract]
  publication-title: Neurology
– volume: 135
  start-page: 669
  year: 1978
  end-page: 675
  article-title: Levodopa‐induced psychosis: a kindling phenomenon
  publication-title: Am J Psychiatry
– year: 1990
– volume: 40
  start-page: 271
  year: 1984
  end-page: 277
  article-title: Psychiatric complications of levodopa therapy of Parkinson's disease
  publication-title: Adv Neurol
– volume: 45
  start-page: 1305
  year: 1995
  end-page: 1308
  article-title: Psychosis in advanced Parkinson's disease: treatment with ondansetron, a 5‐HT3 antagonist
  publication-title: Neurology
– volume: 14
  start-page: 136
  year: 1983
  article-title: Hallucinations in Parkinson's disease: a population study [Abstract]
  publication-title: Neurology
– start-page: 63
  volume-title: Sleep-Related Disorders and Internal Diseases
  year: 1987
  ident: 10.1002/1531-8257(199901)14:1<117::AID-MDS1019>3.0.CO;2-0-BIB9
  doi: 10.1007/978-3-642-72560-9_5
– volume: 50
  start-page: 515
  year: 1998
  ident: 10.1002/1531-8257(199901)14:1<117::AID-MDS1019>3.0.CO;2-0-BIB2B
  publication-title: Neurology
  doi: 10.1212/WNL.50.2.515
– volume: 135
  start-page: 669
  year: 1978
  ident: 10.1002/1531-8257(199901)14:1<117::AID-MDS1019>3.0.CO;2-0-BIB8
  publication-title: Am J Psychiatry
  doi: 10.1176/ajp.135.6.669
– volume: 53
  start-page: 1265
  year: 1996
  ident: 10.1002/1531-8257(199901)14:1<117::AID-MDS1019>3.0.CO;2-0-BIB2A
  publication-title: Arch Neurol
  doi: 10.1001/archneur.1996.00550120077019
– volume: 12
  start-page: 397
  year: 1971
  ident: 10.1002/1531-8257(199901)14:1<117::AID-MDS1019>3.0.CO;2-0-BIB5
  publication-title: Int J Clin Pharmacol Ther
  doi: 10.1002/cpt1971122part2397
– volume-title: The Scale for the Assessment of Positive Symptoms (SAPS)
  year: 1984
  ident: 10.1002/1531-8257(199901)14:1<117::AID-MDS1019>3.0.CO;2-0-BIB10
– volume: 48
  start-page: a370
  year: 1997
  ident: 10.1002/1531-8257(199901)14:1<117::AID-MDS1019>3.0.CO;2-0-BIB15
  publication-title: Neurology
– volume: 43
  start-page: 143
  year: 1978
  ident: 10.1002/1531-8257(199901)14:1<117::AID-MDS1019>3.0.CO;2-0-BIB6
  publication-title: J Neural Transm
  doi: 10.1007/BF01579073
– volume: 14
  start-page: 136
  year: 1983
  ident: 10.1002/1531-8257(199901)14:1<117::AID-MDS1019>3.0.CO;2-0-BIB1
  publication-title: Neurology
– volume-title: Brainstem Control of Wakefulness and Sleep
  year: 1990
  ident: 10.1002/1531-8257(199901)14:1<117::AID-MDS1019>3.0.CO;2-0-BIB11
  doi: 10.1007/978-1-4757-4669-3
– volume: 39
  start-page: 1219
  year: 1989
  ident: 10.1002/1531-8257(199901)14:1<117::AID-MDS1019>3.0.CO;2-0-BIB14
  publication-title: Neurology
  doi: 10.1212/WNL.39.9.1219
– volume: 45
  start-page: 1305
  year: 1995
  ident: 10.1002/1531-8257(199901)14:1<117::AID-MDS1019>3.0.CO;2-0-BIB13
  publication-title: Neurology
  doi: 10.1212/WNL.45.7.1305
– volume: 43
  start-page: 92
  year: 1993
  ident: 10.1002/1531-8257(199901)14:1<117::AID-MDS1019>3.0.CO;2-0-BIB3
  publication-title: Neurology
– volume: 37
  start-page: 175
  year: 1975
  ident: 10.1002/1531-8257(199901)14:1<117::AID-MDS1019>3.0.CO;2-0-BIB12
  publication-title: J Neural Transm
  doi: 10.1007/BF01663632
– volume: 45
  start-page: 669
  year: 1995
  ident: 10.1002/1531-8257(199901)14:1<117::AID-MDS1019>3.0.CO;2-0-BIB4
  publication-title: Neurology
  doi: 10.1212/WNL.45.4.669
– volume: 40
  start-page: 271
  year: 1984
  ident: 10.1002/1531-8257(199901)14:1<117::AID-MDS1019>3.0.CO;2-0-BIB7
  publication-title: Adv Neurol
SSID ssj0011516
Score 2.0136812
Snippet In a series of consecutively randomized outpatients who had Parkinson's disease (PD), we examined the association of three behaviors: sleep fragmentation,...
SourceID proquest
pubmed
pascalfrancis
crossref
wiley
istex
SourceType Aggregation Database
Index Database
Publisher
StartPage 117
SubjectTerms Adult
Aged
Aged, 80 and over
Biological and medical sciences
Degenerative and inherited degenerative diseases of the nervous system. Leukodystrophies. Prion diseases
Delusions - diagnosis
Dream phenomenon
Dreams
Female
Hallucinations
Hallucinations - diagnosis
Humans
Illusions
Male
Medical sciences
Middle Aged
Neurology
Parkinson Disease - diagnosis
Parkinson's disease
Sleep fragmentation
Sleep Wake Disorders - diagnosis
Title Hallucinations, sleep fragmentation, and altered dream phenomena in Parkinson's disease
URI https://api.istex.fr/ark:/67375/WNG-BC1LBX1B-0/fulltext.pdf
https://onlinelibrary.wiley.com/doi/abs/10.1002%2F1531-8257%28199901%2914%3A1%3C117%3A%3AAID-MDS1019%3E3.0.CO%3B2-0
https://www.ncbi.nlm.nih.gov/pubmed/9918353
https://www.proquest.com/docview/21145904
https://www.proquest.com/docview/69562359
Volume 14
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwvV3da9swEBelg7KXfZdlXTc9LPuAOrUsybayMWiSdllZUthamjchW3IZS90yJzD2d-wP3p3lpMvoHgZj4AdjjA6d7qTfSXc_EfIsN8KKLM8DG7M0gPU4DYyJZMBSx2Nnw0LWTEyjcTw8EYcTOVkj1aIWxvNDLDfc0DPq-Rod3GTV7hVpKLgqCyC-SZDQSOHxDsTOTCAFQZv3GUvgDZ6994NgNPgElqfafJ93wk7_qM17UYBxPuMx8u0PPi4ppwAg1delgvPJurJ4g6hG5u5S4ksv7xUTXfYGJHW7v0h562W8Bgkra90NHLZvmHtpKlB_4e_NuA7YruLkeqE7uE1-LFTk81u-dOazrJN__4098j_r8A651QBnuuct_S5Zc-U9sjFqUgPuk9OhmU7n8O63IHdoNXXukoICzs6b-qpyh5rS0jpBwFlqAS-fU8xxQxYKQz-XFGvA63K4FxVtjq4ekJOD_eP-MGhujQhyAIMqSAzjDiuSlU3ztBBSFlLFGeDcLHdplgtWxMpGRWxtyAG8AWQRJuQ2sZGAuV7xTbJeXpTuIaFcho4nzNo0ccKyArnMErxwXiS5g88tcrgYX33pyUG0p4GONKpWo2q1VyzEWJohtbrWoE7dqFNzHer-kY502CLPawtZtgQ9xqy7ROrT8Tvd67MPvQnr4Y_bKyZ0JRpiyUjELfJ0YVIa5go8ADKlu5hXGoJ9IVUo_vxHrBAPS9Uim94Wl41DHAFgnbfIuDaov-jv9d1dfHr0rxvcIjc9tQZukz0m67Ovc7cNwHGWPak9_SdZXkrf
linkProvider Wiley-Blackwell
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwvV3da9swEBelhW4v-y7ztq56WPYBdWpZkm1lY9Ak7dIuSWFrad6EbcmjNHXLksDY_7H_d3eWky6jexiMgR-MMTp0upN-J939RMiLPBVGZHnum4glPqzHiZ-mofRZYnlkTVDIiolpMIx6J-JwJEcrZDqvhXH8EIsNN_SMar5GB8cN6Z1r1lDwVeZDgBMjo5HC8x0InplADoIG7zAWwxs8uwddf9D9DKanGnyPN4Nm56jB26EPgf6aAICCIVv304J0CiBSdWEquJ-saovXiaqF7ixEvnYC3zDRYu9AVKv1i5j3TshbELG02q3hwH3D7Mt0AgNQuJszboK2y0i5Wur275IfcyW5DJfz5myaNfPvv_FH_m8t3iN3auxMd52x3ycrtnxA1gd1dsBDctpLx-MZvLtdyG06GVt7RUEDXy7qEqtym6aloVWOgDXUAGS-oJjmhkQUKT0rKZaBVxVxrya0Pr16RE729447Pb--OMLPAQ8qP04Zt1iUrEySJ4WQspAqygDqZrlNslywIlImLCJjAg74DVCLSANuYhMKmO4V3yCr5WVpHxPKZWB5zIxJYisMK5DOLMY750WcW_jskcP5AOsrxw-iHRN0qFG1GlWrnWIhzNIM2dW1BnXqWp2a60B3jnSoA4-8rExk0RL0GBPvYqlPhx90u8P67RFr44-bSzZ0LRrCyVBEHtma25SG6QLPgNLSXs4mGuJ9IVUg_vxHpBASS-WRDWeMi8YhlAC8zj0yrCzqL_p7c3fnn5786wa3yK3e8aCv-wfDj0_Jbce0gbtmz8jq9OvMbgKOnGbPK7f_CTiaTv4
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwvV3da9swEBelhbCXfZdlXVc9LPuAOrUsybayMWiSZmnXpKNbad6EbcllLHXDksDY37E_eHeWky6jexiMgR-MMTp0upN-J939RMizLBFGpFnmmZDFHqzHsZckgfRYbHlojZ_LkolpMAz7Z-JoJEdrZLqohXH8EMsNN_SMcr5GB5-YfO-aNBRclXkQ30RIaKTweAdiZyaQgqDBO4xF8AbP_mHXG3Q_guWpBj_gTb_ZOWnwduBBnL8hQkAgiKROl5xTgJDK-1LB-2RZWlwjqhK6txT50gl8xUSLvQFRrdYvYt46Ia9BxMpit4Hj9g2TL5Mp6D93F2fchGxXgXK50vXukB8LHbkEly_N-SxtZt9_o4_8z0q8S25XyJnuO1O_R9ZscZ_UBlVuwANy3k_G4zm8uz3IXTodWzuhoICLy6rAqtilSWFomSFgDTUAmC8pJrkhDUVCPxcUi8DLergXU1qdXT0kZ72DT52-V10b4WWABpUXJYxbLElWJs7iXEiZSxWmAHTTzMZpJlgeKhPkoTE-B_QGmEUkPjeRCQRM9opvkvXiqrCPCOXStzxixsSRFYblSGYW4Y3zIsosfK6To8X46oljB9GOBzrQqFqNqtVOsRBkaYbc6lqDOnWlTs21rzsnOtB-nTwvLWTZEvQY0-4iqc-H73S7w47bI9bGH7dXTOhaNASTgQjrZGdhUhomCzwBSgp7NZ9qiPaFVL748x-hQkAsVZ1sOltcNg6BBKB1XifD0qD-or83d3fx6fG_bnCH1D50e_r4cPh-i9xyNBu4ZfaErM--zu02gMhZ-rR0-p_THk2t
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Hallucinations%2C+sleep+fragmentation%2C+and+altered+dream+phenomena+in+Parkinson%27s+disease&rft.jtitle=Movement+disorders&rft.au=PAPPERT%2C+E.+J&rft.au=GOETZ%2C+C.+G&rft.au=NIEDERMAN%2C+F.+G&rft.au=RAMAN%2C+R&rft.date=1999&rft.pub=Wiley&rft.issn=0885-3185&rft.volume=14&rft.issue=1&rft.spage=117&rft.epage=121&rft_id=info:doi/10.1002%2F1531-8257%28199901%2914%3A1%3C117%3A%3AAID-MDS1019%3E3.0.CO%3B2-0&rft.externalDBID=n%2Fa&rft.externalDocID=1642246
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0885-3185&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0885-3185&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0885-3185&client=summon